US · Healthcare · Medical Instruments & Supplies
EPS came in at 0.56 against a street estimate of 0.36 — a beat of 55.6%.
Analysts rate Baxter International Inc a hold (6 buy, 11 hold, 1 sell out of 18) with an average price target of $28.73.
CONFIDENT Baxter beat Q2 expectations with 5% organic revenue growth and raised full-year guidance. Drug compounding and Advanced Surgery drove strength. $75M tariff refund aided EPS, but underlying operational performance also exceeded expectations. Q2 2026 Both U.S. and international markets showed growth; no granular breakdown provided. Dynamo stretcher launched in Canada as first international expansion. Analysts pressed on drug compounding mix impact, Novum IQ timelines, and 2027 EPS sustainability. Management downplayed single-quarter wins, emphasized GPS-driven operational cadence, and deferred 2027 guidance pending H2 execution. 2026-07-30…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 15.36% |
| Pzena Investment Management, LLC | 12.48% |
| Dodge & Cox | 11.29% |
| FMR Inc | 8.95% |
| Vanguard Capital Management, LLC | 6.48% |
| Vanguard Portfolio Management, LLC | 4.64% |
| State Street Corp | 3.86% |
| Greenhaven Associates Inc | 2.76% |
| Document | Date |
|---|---|
| Board / officer change · Q3 2026 BAXTER INTERNATIONAL INC. – 8-K SUMMARY HEADLINE NUMBERS • New CFO appointment effective October 1, 2026: John Rogers joins as Executive Vice Presid | 2026-08-19 |
| Material agreement · Q3 2026 BAXTER INTERNATIONAL INC. - FORM 8-K SUMMARY August 18, 2026 --- HEADLINE NUMBERS • Company increased aggregate purchase price cap for debt tender | 2026-08-18 |
| Board / officer change · Q3 2026 BAXTER INTERNATIONAL INC. - 8-K SUMMARY OTHER NOTABLE POINTS • Executive Departure: Interim Chief Financial Officer Anita Zielinski resigned effecti | 2026-08-04 |
| Company announcement · Q3 2026 BAXTER INTERNATIONAL INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Company announced cash tender offers on August 4, 2026 to repurchase up to $500 mill | 2026-08-04 |
| Quarterly report · Q2 2026 BAXTER INTERNATIONAL INC. - Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Q2 2026 Net Sales: $2,960 million (up 5.3% vs. $2,810 million in Q2 2025) • Six- | 2026-07-30 |
| Quarterly report · Q1 2026 BAXTER INTERNATIONAL INC. - Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Net sales: $2,701 million (Q1 2026) vs. $2,625 million (Q1 2025) — up 2.9% • Ope | 2026-04-30 |
| Proxy statement · Q2 2026 BAXTER INTERNATIONAL INC. — 2026 PROXY STATEMENT SUMMARY --- CEO COMPENSATION • Andrew Hider (President and CEO since August 2025) total compensati | 2026-03-23 |
| Annual report FY2025 BAXTER INTERNATIONAL INC. — 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Market capitalization: Approximately $16 billion as of June 30, 202 | 2026-02-12 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.01 / share ex-date Aug 28, 2026 · pay Oct 1, 2026 | 2026-08-28 |
| Dividend | $0.01 / share ex-date May 29, 2026 · pay Jul 1, 2026 | 2026-05-29 |
| Dividend | $0.01 / share ex-date Feb 27, 2026 · pay Apr 1, 2026 | 2026-02-27 |
| Dividend | $0.01 / share ex-date Nov 28, 2025 · pay Jan 2, 2026 | 2025-11-28 |
| Dividend | $0.17 / share ex-date Aug 29, 2025 · pay Oct 1, 2025 | 2025-08-29 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Baxter International Inc — free to start.
Google PlayApp StoreData updated 2026-09-18.